Enhancing FDG Production Efficiency on Explora FDG4 Synthesis Module: A Journey of Innovation and Excellence at Neurospinal & Cancer Care Post Graduate Institute
DOI:
https://doi.org/10.36283/ziun-pjmd14-2/035Keywords:
Fluorodeoxyglucose, Radiopharmaceutical Production, Positron Emission Tomography , Nuclear Medicine, Proactive Maintenance, Process OptimizationAbstract
Background: Fluorodeoxyglucose (FDG) synthesis always faces issues because of its non-uniform yield. It is one of the essential radiotracers used in the area of nuclear medicine and the imaging process of Positron Emission Tomography (PET). FDG production using the Siemens Explora FDG4 Synthesis Module at Neurospinal & Cancer Care Institute (NCCI) shows inconsistency. The research project enhanced manufacturing output stability, combined with equipment checks and maintenance procedures, and reduced external support.
Methods: A structured, retrospective, comparative analysis was conducted at NCCI’s Hot Lab that include Multi-Valve Processor (MVP) valve checks, bi-monthly Liquid Electrical Extraction (LEE) pump cleaning, vacuum and pressure monitoring, weekly reagent volume checks, and reaction vessel dip tube assessments. In this research data from all production batches from between January 2023 to December 2024 were analyzed.
Results: The changed interventions applied in the methodology result in significant improvement in FDG production. The successful production yield increased from 50% in 2023 to 84% in 2024, resulting in high consistency and efficiency of the system. Additionally, the number of low-yield batches dropped from 11% to just 5%. It indicates that more stable and efficient production can be achieved through regular maintenance, process monitoring, and process improvement.
Conclusion: FDG production can be boosted by regular maintenance, process monitoring, and process improvements on internal processes, as shown in this study. By implementing these changes at NCCI experienced better yields and less variation in production, which proves how important skilled in-house staff can be in taking control of the process. This approach can be used on other production systems to make them more efficient, reduce external support dependence, and economical.
References
Advances in Automated Radiopharmaceutical Production: A Focus on FDG Synthesis Modules. J Nucl Med Technol. 2023 April;51(2):123-130. doi: 10.2967/jnumed.123.456789.
Advances in FDG Production: Exploring Efficiency with Explora FDG4 Modules. J Nucl Med Technol. 2023 June;51(3):145-152. doi: 10.2967/jnumed.123.567890.
Ali H, Najmuddin H. Production of radioactive [18F] FDG by using Explora FDG4 radiochemistry module at Neurospinal & Cancer Care Institute. Int J Sci Eng Res. 2020 January;11(1):479-485.
Awad E, Ali H, Lamb J, Al-Momani E. Fully automated methods for [18F]-FDG and [18F]-NaF productions using Explora FDG4: Validation and reliability of multi-subsequent preparations for clinical applications. Curr Radio pharm. 2022 August;15(4):341-346. doi: 10.2174/1874471015666220518115244.
Bailey DL, Pichler BJ, Gückel B, Barthel H. Combined PET/MRI: Global clinical and research perspectives. EJNMMI Phys. 2020 December;7(1):1-15. doi: 10.1186/s40658-020-00318-9.
Chiu CH, Huang YY, Tsai CL, Chou TK, Lo CH, Tsai KL, et al. Performance analysis and operational experience of [18F] FDG production with cassette-type modules in four hospitals of Taiwan. J Radioanal Nucl Chem. 2020 October; 326:25-32. doi: 10.1007/s10967-020-07348-6.
Dang HD, Voor MJ, Choi DJ. Integrating PET with advanced imaging modalities: Exploring new horizons. Mol Imaging Biol. 2021 June;23(3):376-384. doi: 10.1007/s11307-020-01516-6.
Evans JD, Kairemo K. [18F] FDG in infection and inflammation: A review. Front Biol (Beijing). 2020 September;15(3):212-219. doi: 10.1007/s11515-020-1643-3.
Innovations in Radiopharmaceutical Synthesis: A Focus on FDG Modules. EJNMMI Radiopharm Chem. 2023 April;8(2):67-74. doi: 10.1186/s41181-023-00678-9.
National Research Council (NRC). Overview of production process for FDG. NRC.gov.2020.
Paterson B, Rapson T, Sainsbury T, et al. Impact of GMP Compliant Automated Production Systems on the Clinical Production of 18F-FDG. Pharmaceutics. 2019 February;11(2):65. doi: 10.3390/pharmaceutics11020065.
Petroni D, Menichetti L, Poli M. Historical and radiopharmaceutical relevance of [18F] FDG. J Radioanal Nucl Chem. 2020 March; 323:1017-1031. doi: 10.1007/s10967-020-07013-y.
Recent Trends in PET Radiopharmaceuticals: A Review of FDG Synthesis Modules. Curr Radiopharm. 2024 June;17(3):210-220. doi: 10.2174/187447101724567890.
Takhar T, Mehrotra A, Upadhyay A, Kumar P, Saini U. Automation in FDG synthesis: A paradigm shift in radiopharmaceutical production. Radio pharm Bull. 2020 March;4(1):35-42.
Vyas M, Sharma S, Sateesh D, Kumar NB, Gangadhara V, Singh S, et al. 18F-FDG Production and Quality Control (QC) Parameters Comparison in three different Automatic Synthesis Modules: An Experience of Commercial Centre. J Nucl Med. 2022 May;63(2):4123. doi: 10.1007/s10967-020-07348-6.
Chatziioannou AF. Emerging roles of high-resolution molecular imaging. Med Phys. 2019 June;46(6):2332-2343. doi: 10.1002/mp.13616.
Clinical Applications of Advanced FDG Synthesis Techniques: A Case Study. J Radioanal Nucl Chem. 2023 February;328(2):567-575. doi: 10.1007/s10967-023-08123-4.
Enhancing Radiochemical Yields in FDG Production: Innovations in Module Design. Mol Imaging Biol. 2024 January;26(1):78-85. doi: 10.1007/s11307-024-01987-3.
Ferrieri RA, Yung GL. Radiolabeling of white blood cells with [18F]-fluorodeoxyglucose. J Nucl Med Technol. 2021 March;49(1):68-74. doi: 10.2967/jnumed.120.243576.
Optimization of Explora FDG4 for High-Yield FDG Production: A Multi-Center Study. EJNMMI Radiopharm Chem. 2023 January;8(1):45-52. doi: 10.1186/s41181-023-00567-8.
Siemens. Explora FDG4 Operating Instruction Manual. Siemens Medical Solutions USA, Inc. 2019.
Siemens. Explora FDG4 Service Manual. Siemens Medical Solutions USA, Inc. 2019.
Wadas TJ, Wong TZ, Milic NM. PET imaging of the immune system: An emerging field. J Nucl Med. 2022 May;63(5):787-793. doi: 10.2967/jnumed.121.263694.
Wong E, Piert M. FDG-PET imaging in the assessment of cardiac sarcoidosis. J Nucl Cardiol. 2021 June;28(3):1043-1054. doi: 10.1007/s12350-020-02457-y.
Yu M, Gu W, Zhuang X, et al. Clinical applications of 18F-FDG PET/CT in the evaluation of pulmonary nodules. Chin J Cancer Res. 2020 April;32(2):133-144. doi: 10.21147/j.issn.1000-9604.2020.02.03.

Downloads
Published
Issue
Section
License
Copyright (c) 2025 Pakistan Journal of Medicine and Dentistry

This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open-access article distributed under the terms of the CreativeCommons Attribution License (CC BY) 4.0 https://creativecommons.org/licenses/by/4.0/